I've lived solely in the Wuxi New District, in various locations up and down Changjiang North Road. I'd been running for a ...

A Chinese pharmaceutical company expects to hire up to 500 employees for the first phase of its new campus in northern ...

China executed two men responsible for deadly November 2024 attacks. Fan Weiqu, 62, killed 35 in a car rampage in Zhuhai, ...

As one of four sub-venues for this year's Chunwan, or Spring Festival Gala, Wuxi in East China's Jiangsu province is pulling ...

NAMSA recently announced plans to acquire WuXi AppTec’s medical device testing operations in the U.S. As part of the ...

WuXi Biologics is expected to deliver faster sales growth and higher margins this year. Click here to find out why I upgraded ...

China has executed two men who committed deadly attacks that killed dozens in November, raising concerns about a surge in ...

China has executed a man who killed 35 people by plowing his car into crowds at a sports center in November, in the country’s ...

At the JP Morgan Conference 2025, CEO Chen said the potential of the Biosecure Act passing has had only a minimal chilling ...

WuXi AppTec sells US device testing sites to NAMSA, Notch Therapeutics cuts staff, and Neurizon's ALS drug NUZ-001 faces FDA clinical hold.

WuXi AppTec is parting ways with its U.S. medical device testing business, selling its two stateside locations to the Ohio-based regulatory consulting firm NAMSA. | The deal includes facilities in ...